Facebook Twitter Instagram
    Trending
    • Kirk moderator to join Pope and Archbishop of Canterbury on peace trip
    • Doctor arrested over defiling a 12-year-old senior one student
    • Authorities in Nyakabingo S/C to enact by-laws against alcohol consumption & sale during burial ceremonies
    • LC3 Bukonzo west Constituency tracks unionism in communal works
    • Pilgrims walk, run from Munyonyo to Kampala ahead of Martyrs day
    • Egypt: Somali teen who allegedly killed attacker released
    • Uganda Committed To The Success Of EAC Armed Forces Exercise Ushirikiano Imara 2022
    • Ugandan Family Physician dies in chaotic hit and run accident in Nakawa as she reports for duty
    Facebook Twitter LinkedIn Pinterest RSS
    Kasese Guide Radio Kasese Guide Radio
    Listen on Online Radio Box! Kasese Guide Radio Kasese Guide Radio
    • Home
    • About Us
      • KGR Staff
      • Presenters
      • Priests
    • Radio Shows
      • Program Segments
      • Weekend Programs
      • Special Programs
    • Departments
      • Administration
      • Technical
      • Marketing
      • News
      • Programming
      • Finance
    • News
    • Contacts
    • Shop
    Donate
    Kasese Guide Radio Kasese Guide Radio
    You are at:Home » Blog » First quantities of malaria drug hydroxychloroquine to be produced.
    Local

    First quantities of malaria drug hydroxychloroquine to be produced.

    News EditorBy News EditorMay 28, 2020No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email

    Local pharmaceutical Company Cipla Quality Chemicals Industries will this weekend produce its first quantities of malaria drug hydroxychloroquine, which has also been used in the treatment of people with Coronavirus Disease.

    The company Executive Director Nevin J. Bradford told the press that they received raw materials that are sufficient for 300,000 doses initially.

    Production of the drug, however, starts at the time of controversy about the effectiveness of the drug with the World Health Organization  announcing on Monday that the drug had been removed from the list of drugs that they were giving to patients participating in their global treatment trial dubbed ‘solidarity’ which has over 17 countries involved.  

    Dr Tedros Adhanom Ghebreyesus, the WHO Director-General told journalists that they decided this removal after new evidence emerged that patients who used the drug either alone or in a combination of an antibiotic had higher mortality rates and heart problems than those who were not.

    With these findings, Dr Diana Atwine, the Permanent Secretary in the Ministry of Health told Journalists today that while the production is welcome, they are no longer keen about having this drug.

    Dr. Atwine on Drugs Speaking;…..

    Mr. Bradford explained that while the first production is specific to the response, they are set to broaden their product portfolio to include the manufacture of medicine for the treatment of cardiovascular conditions, diabetes and cancer.

    However, apart from the new drug, CIPLAQC also makes anti-malarial drug Lumartem,  and antiviral drugs for HIV which are sold across the region.    

    Ends .

    Post Views: 160
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Authorities in Nyakabingo S/C to enact by-laws against alcohol consumption & sale during burial ceremonies

    LC3 Bukonzo west Constituency tracks unionism in communal works

    Ugandan Family Physician dies in chaotic hit and run accident in Nakawa as she reports for duty

    Add A Comment

    Leave A Reply Cancel Reply

    Recent Posts
    • Kirk moderator to join Pope and Archbishop of Canterbury on peace trip
    • Doctor arrested over defiling a 12-year-old senior one student
    • Authorities in Nyakabingo S/C to enact by-laws against alcohol consumption & sale during burial ceremonies
    • LC3 Bukonzo west Constituency tracks unionism in communal works
    • Pilgrims walk, run from Munyonyo to Kampala ahead of Martyrs day
    Kasese Guide Radio

    We are a commercial project of the Catholic Church (Diocese of Kasese). It is fully licensed and regulated by the Uganda Communications Commission (UCC) and Broadcasting Council, transmitting on the hills of Kigabiro, Bunyaruguru in Rubirizi District.

    Contacts

    Station Receiption-Kasese
    0773597166 / 0392884995
    info@kaseseguideradio.com
    www.kaseseguideradio.com

    Our Visitors
    022703
    Users Today : 16
    Users This Month : 767
    Users This Year : 3217
    Who's Online : 0
    Powered By WPS Visitor Counter
    Copyright © 2022 Kasese Guide Radio | Powered By Kasese Catholic Diocese | Website By JulyBrands

    Type above and press Enter to search. Press Esc to cancel.

    Go to mobile version